1	Active	Active	B-NP	JJ	O	3	NMOD	-1
2	hair	hair	I-NP	NN	O	3	NMOD	-1
3	growth	growth	I-NP	NN	O	7	SUB	4	growth
4	(	(	O	(	O	6	DEP	-1
5	anagen	anagen	B-NP	NN	O	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	associated	associate	I-VP	VBN	O	7	VC	16	associated
9	with	with	B-PP	IN	O	8	VMOD	-1
10	angiogenesis	angiogenesis	B-NP	NN	O	9	PMOD	3	angiogenesis
11	.	.	O	.	O	7	P	-1

1	After	After	B-PP	IN	O	0	ROOT	-1
2	the	the	B-NP	DT	O	3	NMOD	-1
3	completion	completion	I-NP	NN	O	1	PMOD	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	skin	skin	B-NP	NN	O	6	NMOD	-1
6	development	development	I-NP	NN	O	22	SUB	2	development
7	,	,	O	,	O	22	P	-1
8	angiogenesis	angiogenesis	B-NP	NN	O	22	SUB	3	angiogenesis
9	,	,	O	,	O	22	P	-1
10	i.e.	i.e.	B-NP	FW	O	22	VMOD	-1
11	,	,	O	,	O	22	P	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	growth	growth	I-NP	NN	O	22	SUB	4	growth
14	of	of	B-PP	IN	O	13	NMOD	-1
15	new	new	B-NP	JJ	O	16	NMOD	-1
16	capillaries	capillary	I-NP	NNS	O	14	PMOD	-1
17	from	from	B-PP	IN	O	16	NMOD	-1
18	pre-existing	pre-existing	B-NP	JJ	O	20	NMOD	-1
19	blood	blood	I-NP	NN	O	20	NMOD	-1
20	vessels	vessel	I-NP	NNS	O	17	PMOD	-1
21	,	,	O	,	O	13	P	-1
22	is	be	B-VP	VBZ	O	4	SBAR	-1
23	held	hold	I-VP	VBN	O	22	VC	-1
24	to	to	I-VP	TO	O	25	VMOD	-1
25	occur	occur	I-VP	VB	O	23	VMOD	-1
26	in	in	B-PP	IN	O	25	VMOD	-1
27	the	the	B-NP	DT	O	28	NMOD	-1
28	skin	skin	I-NP	NN	O	26	PMOD	-1
29	only	only	B-ADVP	RB	O	30	PMOD	-1
30	under	under	B-PP	IN	O	25	VMOD	-1
31	pathologic	pathologic	B-NP	JJ	O	32	NMOD	-1
32	conditions	condition	I-NP	NNS	O	30	PMOD	-1
33	.	.	O	.	O	1	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	has	have	B-VP	VBZ	O	0	ROOT	-1
3	long	long	I-VP	RB	O	2	VMOD	-1
4	been	be	I-VP	VBN	O	2	VC	-1
5	noted	note	I-VP	VBN	O	4	VC	-1
6	,	,	O	,	O	2	P	-1
7	however	however	B-ADVP	RB	O	2	VMOD	-1
8	,	,	O	,	O	2	P	-1
9	that	that	B-SBAR	IN	O	2	VMOD	-1
10	hair	hair	B-NP	NN	O	12	NMOD	-1
11	follicle	follicle	I-NP	NN	O	12	NMOD	-1
12	cycling	cycling	I-NP	NN	O	13	SUB	2	cycling
13	is	be	B-VP	VBZ	O	9	SBAR	-1
14	associated	associate	I-VP	VBN	O	13	VC	16	associated
15	with	with	B-PP	IN	O	14	VMOD	-1
16	prominent	prominent	B-NP	JJ	O	17	NMOD	-1
17	changes	change	I-NP	NNS	O	15	PMOD	0
18	in	in	B-PP	IN	O	17	NMOD	-1
19	skin	skin	B-NP	NN	O	20	NMOD	-1
20	perfusion	perfusion	I-NP	NN	O	18	PMOD	0
21	,	,	O	,	O	2	P	-1
22	that	that	B-SBAR	IN	O	35	DEP	-1
23	the	the	B-NP	DT	O	26	NMOD	-1
24	epithelial	epithelial	I-NP	JJ	B-protein	26	NMOD	-1
25	hair	hair	I-NP	NN	I-protein	26	NMOD	-1
26	bulbs	bulb	I-NP	NNS	I-protein	30	SUB	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	anagen	anagen	B-NP	NN	O	29	NMOD	-1
29	follicles	follicle	I-NP	NNS	O	27	PMOD	-1
30	display	display	B-VP	VBP	O	22	SBAR	-1
31	angiogenic	angiogenic	B-NP	JJ	O	32	NMOD	3	angiogenic
32	properties	property	I-NP	NNS	O	30	OBJ	0
33	,	,	O	,	O	35	P	-1
34	and	and	O	CC	O	35	DEP	-1
35	that	that	B-SBAR	IN	O	2	VMOD	-1
36	the	the	B-NP	DT	O	39	NMOD	-1
37	follicular	follicular	I-NP	JJ	O	38	AMOD	-1
38	dermal	dermal	I-NP	JJ	O	39	NMOD	-1
39	papilla	papilla	I-NP	NN	O	40	SUB	-1
40	can	can	B-VP	MD	O	35	SBAR	-1
41	produce	produce	I-VP	VB	O	40	VC	0
42	angiogenic	angiogenic	B-NP	JJ	B-protein	43	NMOD	3	angiogenic
43	factors	factor	I-NP	NNS	I-protein	41	OBJ	-1
44	.	.	O	.	O	2	P	-1

1	Despite	Despite	B-PP	IN	O	9	VMOD	-1
2	these	these	B-NP	DT	O	4	NMOD	-1
3	suggestive	suggestive	I-NP	JJ	O	4	NMOD	-1
4	observations	observation	I-NP	NNS	O	1	PMOD	-1
5	,	,	O	,	O	9	P	-1
6	no	no	B-NP	DT	O	8	NMOD	-1
7	formal	formal	I-NP	JJ	O	8	NMOD	-1
8	proof	proof	I-NP	NN	O	9	SUB	-1
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	as	as	B-PP	RB	O	9	PRD	-1
11	yet	yet	B-ADJP	RB	O	10	AMOD	-1
12	available	available	I-ADJP	JJ	O	10	AMOD	-1
13	for	for	B-PP	IN	O	10	AMOD	-1
14	the	the	B-NP	DT	O	15	NMOD	-1
15	concept	concept	I-NP	NN	O	13	PMOD	-1
16	that	that	B-SBAR	IN	O	15	NMOD	-1
17	angiogenesis	angiogenesis	B-NP	NN	O	18	SUB	3	angiogenesis
18	is	be	B-VP	VBZ	O	16	SBAR	-1
19	a	a	B-NP	DT	O	21	NMOD	-1
20	physiologic	physiologic	I-NP	JJ	O	21	NMOD	-1
21	event	event	I-NP	NN	O	18	PRD	-1
22	that	that	B-NP	WDT	O	21	NMOD	-1
23	occurs	occur	B-VP	VBZ	O	22	SBAR	-1
24	all	all	B-PP	DT	O	23	VMOD	-1
25	over	over	I-PP	IN	O	24	PMOD	-1
26	the	the	B-NP	DT	O	29	NMOD	-1
27	mature	mature	I-NP	JJ	O	29	NMOD	-1
28	mammalian	mammalian	I-NP	JJ	O	29	NMOD	-1
29	integument	integument	I-NP	NN	O	25	PMOD	-1
30	whenever	whenever	B-ADVP	WRB	O	29	NMOD	-1
31	hair	hair	B-NP	NN	O	32	NMOD	-1
32	follicles	follicle	I-NP	NNS	O	33	SUB	-1
33	switch	switch	B-VP	VBP	O	30	SBAR	-1
34	from	from	B-PP	IN	O	33	VMOD	-1
35	resting	rest	B-VP	VBG	O	34	PMOD	4	resting
36	(	(	O	(	O	38	DEP	-1
37	telogen	telogen	B-NP	NN	O	38	DEP	-1
38	)	)	O	)	O	35	VMOD	-1
39	to	to	B-PP	TO	O	33	VMOD	-1
40	active	active	B-NP	JJ	O	41	NMOD	-1
41	growth	growth	I-NP	NN	O	39	PMOD	4	growth
42	(	(	O	(	O	44	DEP	-1
43	anagen	anagen	B-NP	NN	O	44	DEP	-1
44	)	)	O	)	O	41	NMOD	-1
45	.	.	O	.	O	9	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	study	study	I-NP	NN	O	3	SUB	-1
3	uses	use	B-VP	VBZ	O	0	ROOT	-1
4	quantitative	quantitative	B-NP	JJ	O	5	NMOD	-1
5	histomorphometry	histomorphometry	I-NP	NN	O	9	NMOD	-1
6	and	and	O	CC	O	9	NMOD	-1
7	double-immunohistologic	double-immunohistologic	B-NP	JJ	O	9	NMOD	-1
8	detection	detection	I-NP	NN	O	9	NMOD	-1
9	techniques	technique	I-NP	NNS	O	3	OBJ	-1
10	for	for	B-PP	IN	O	9	NMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	demarcation	demarcation	I-NP	NN	O	10	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	proliferating	proliferate	B-VP	VBG	B-cell_type	16	NMOD	1	proliferating
15	endothelial	endothelial	B-NP	JJ	I-cell_type	16	NMOD	-1
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	-1
17	,	,	O	,	O	3	P	-1
18	to	to	B-VP	TO	O	19	VMOD	-1
19	show	show	I-VP	VB	O	3	VMOD	-1
20	that	that	B-SBAR	IN	O	19	VMOD	-1
21	synchronized	synchronize	B-NP	VBN	O	24	NMOD	-1
22	hair	hair	I-NP	NN	O	24	NMOD	-1
23	follicle	follicle	I-NP	NN	O	24	NMOD	-1
24	cycling	cycling	I-NP	NN	O	29	SUB	2	cycling
25	in	in	B-PP	IN	O	24	NMOD	-1
26	adolescent	adolescent	B-NP	JJ	O	28	NMOD	-1
27	C57BL/6	C57BL/6	I-NP	NN	O	28	NMOD	-1
28	mice	mouse	I-NP	NNS	O	25	PMOD	-1
29	is	be	B-VP	VBZ	O	20	SBAR	-1
30	associated	associate	I-VP	VBN	O	29	VC	16	associated
31	with	with	B-PP	IN	O	30	VMOD	-1
32	substantial	substantial	B-NP	JJ	O	33	NMOD	-1
33	angiogenesis	angiogenesis	I-NP	NN	O	31	PMOD	3	angiogenesis
34	,	,	O	,	O	36	P	-1
35	and	and	O	CC	O	36	DEP	-1
36	that	that	B-SBAR	IN	O	3	VMOD	-1
37	inhibiting	inhibit	B-VP	VBG	O	51	SUB	18	inhibiting
38	angiogenesis	angiogenesis	B-NP	NN	O	37	OBJ	3	angiogenesis
39	in	in	B-ADVP	FW	O	37	VMOD	-1
40	vivo	vivo	I-ADVP	FW	O	39	AMOD	-1
41	by	by	B-PP	IN	O	37	VMOD	-1
42	the	the	B-NP	DT	O	44	NMOD	-1
43	intraperitoneal	intraperitoneal	I-NP	JJ	O	44	NMOD	-1
44	application	application	I-NP	NN	O	41	PMOD	0
45	of	of	B-PP	IN	O	44	NMOD	-1
46	a	a	B-NP	DT	O	49	NMOD	-1
47	fumagillin	fumagillin	I-NP	NN	O	49	NMOD	-1
48	derivative	derivative	I-NP	JJ	O	49	NMOD	-1
49	retards	retard	I-NP	NNS	O	45	PMOD	0
50	experimentally	experimentally	B-ADVP	RB	O	51	VMOD	-1
51	induced	induce	B-VP	VBD	O	36	SBAR	0
52	anagen	anagen	B-NP	NN	O	53	NMOD	-1
53	development	development	I-NP	NN	O	51	OBJ	0
54	in	in	B-PP	IN	O	51	VMOD	-1
55	these	these	B-NP	DT	O	56	NMOD	-1
56	mice	mouse	I-NP	NNS	O	54	PMOD	-1
57	.	.	O	.	O	3	P	-1

1	Thus	Thus	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	angiogenesis	angiogenesis	B-NP	NN	O	4	SUB	3	angiogenesis
4	is	be	B-VP	VBZ	O	0	ROOT	-1
5	a	a	B-NP	DT	O	7	NMOD	-1
6	physiologic	physiologic	I-NP	JJ	O	7	NMOD	-1
7	event	event	I-NP	NN	O	4	PRD	-1
8	in	in	B-PP	IN	O	7	NMOD	-1
9	normal	normal	B-NP	JJ	O	12	NMOD	-1
10	postnatal	postnatal	I-NP	JJ	O	12	NMOD	-1
11	murine	murine	I-NP	JJ	O	12	NMOD	-1
12	skin	skin	I-NP	NN	O	8	PMOD	-1
13	,	,	O	,	O	4	P	-1
14	apparently	apparently	B-ADVP	RB	O	4	VMOD	-1
15	is	be	B-VP	VBZ	O	4	VMOD	-1
16	dictated	dictate	I-VP	VBN	O	15	VC	-1
17	by	by	B-PP	IN	O	16	VMOD	-1
18	the	the	B-NP	DT	O	20	NMOD	-1
19	hair	hair	I-NP	NN	O	20	NMOD	-1
20	follicle	follicle	I-NP	NN	O	17	PMOD	-1
21	,	,	O	,	O	4	P	-1
22	and	and	O	CC	O	4	VMOD	-1
23	appears	appear	B-VP	VBZ	O	4	VMOD	-1
24	to	to	I-VP	TO	O	25	VMOD	-1
25	be	be	I-VP	VB	O	23	VMOD	-1
26	required	require	I-VP	VBN	O	25	VC	0
27	for	for	B-PP	IN	O	26	VMOD	-1
28	normal	normal	B-NP	JJ	O	30	NMOD	-1
29	anagen	anagen	I-NP	NN	O	30	NMOD	-1
30	development	development	I-NP	NN	O	27	PMOD	0
31	.	.	O	.	O	4	P	-1

1	Anagen-associated	Anagen-associated	B-NP	JJ	O	2	NMOD	16	associated
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	offers	offer	B-VP	VBZ	O	19	VMOD	-1
4	an	an	B-NP	DT	O	6	NMOD	-1
5	attractive	attractive	I-NP	JJ	O	6	NMOD	-1
6	model	model	I-NP	NN	O	3	OBJ	-1
7	for	for	B-PP	IN	O	6	NMOD	-1
8	identifying	identify	B-VP	VBG	O	7	PMOD	-1
9	the	the	B-NP	DT	O	11	NMOD	-1
10	physiologic	physiologic	I-NP	JJ	O	11	NMOD	-1
11	controls	control	I-NP	NNS	O	8	OBJ	0
12	of	of	B-PP	IN	O	11	NMOD	-1
13	cutaneous	cutaneous	B-NP	JJ	O	14	NMOD	-1
14	angiogenesis	angiogenesis	I-NP	NN	O	12	PMOD	3	angiogenesis
15	,	,	O	,	O	19	P	-1
16	and	and	O	CC	O	19	NMOD	-1
17	an	an	B-NP	DT	O	19	NMOD	-1
18	interesting	interesting	I-NP	JJ	O	19	NMOD	-1
19	system	system	I-NP	NN	O	0	ROOT	0
20	for	for	B-PP	IN	O	19	NMOD	-1
21	screening	screen	B-VP	VBG	O	20	PMOD	-1
22	the	the	B-NP	DT	O	23	NMOD	-1
23	effects	effect	I-NP	NNS	O	21	OBJ	0
24	of	of	B-PP	IN	O	23	NMOD	-1
25	potential	potential	B-NP	JJ	O	27	NMOD	0
26	antiangiogenic	antiangiogenic	I-NP	JJ	O	27	NMOD	3	angiogenic
27	drugs	drug	I-NP	NNS	O	24	PMOD	-1
28	in	in	B-ADVP	FW	O	27	NMOD	-1
29	vivo	vivo	I-ADVP	FW	O	28	AMOD	-1
30	.	.	O	.	O	19	P	-1

